ARBUTUS BIOPHARMA CORP NPV earnings per share and revenue

0SGC earnings per share for the last quarter are -0.10 USD whereas the estimation was -0.09 USD which accounts for -6.38% surprise. Company revenue for the same period amounts to 1.34 M USD despite the estimated figure of 1.86 M USD. Estimated earnings per share for the next quarter are -0.08 USD, and revenue is expected to reach 1.59 M USD. Also watch annual changes over time to get a bigger picture of 0SGC earnings per share and revenue dynamics.